NeoGenomics, Inc. (NEO)
Healthcare • Diagnostics & Research
StockNasdaqCMUnited StatesUS64049M2098
16.54 USD
-1.72% today Updated 13 Nov 2026 14:05
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by NeoGenomics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 14:05. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
16 Feb 2027
in 95 days · 16:00 · estimate 0.06
Last results
0.07 vs 0.06 estimated
28 Oct 2026 · Beat +26.2%
Beat the estimate
12 of 12
0 missed · 0 in line · 12 beats in a row
Average surprise
+269.9%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 16 Feb 2027 16:00 | 0.06 | — | — | Upcoming |
| 28 Oct 2026 16:00 | 0.06 | 0.07 | +26.2% | Beat |
| 28 Jul 2026 16:00 | 0.03 | 0.05 | +48.6% | Beat |
| 28 Apr 2026 16:00 | — | 0.01 | +800.9% | Beat |
| 17 Feb 2026 07:00 | 0.04 | 0.06 | +50.0% | Beat |
| 28 Oct 2025 07:00 | 0.02 | 0.03 | +25.8% | Beat |
| 29 Jul 2025 07:00 | 0.02 | 0.03 | +21.9% | Beat |
| 29 Apr 2025 07:00 | -0.01 | — | +100.0% | — |
| 18 Feb 2025 07:00 | 0.03 | 0.04 | +40.0% | Beat |
| 05 Nov 2024 07:00 | 0.01 | 0.05 | +500.2% | Beat |
| 29 Jul 2024 16:00 | — | 0.03 | +1,398.7% | Beat |
| 30 Apr 2024 07:00 | -0.03 | -0.02 | +41.5% | Beat |
| 20 Feb 2024 16:00 | -0.03 | 0.03 | +212.5% | Beat |
| 06 Nov 2023 16:00 | -0.08 | -0.02 | +72.0% | Beat |
| 08 Aug 2023 07:00 | -0.11 | -0.05 | +56.1% | Beat |
| 09 May 2023 16:00 | -0.15 | -0.09 | +40.6% | Beat |
| 23 Feb 2023 07:00 | -0.16 | -0.06 | +63.6% | Beat |
| 08 Nov 2022 07:00 | -0.21 | -0.14 | +32.1% | Beat |
| 09 Aug 2022 07:00 | -0.23 | -0.16 | +29.0% | Beat |
| 27 Apr 2022 07:00 | -0.24 | -0.20 | +16.7% | Beat |
| 23 Feb 2022 07:00 | -0.15 | -0.14 | +3.8% | Beat |
| 04 Nov 2021 07:00 | -0.09 | -0.08 | +6.8% | Beat |
| 06 Aug 2021 07:00 | -0.06 | -0.01 | +84.2% | Beat |
| 05 May 2021 07:00 | 0.01 | -0.04 | -540.0% | Miss |
| 24 Feb 2021 07:00 | 0.06 | 0.14 | +133.3% | Beat |
| 27 Oct 2020 08:00 | 0.04 | 0.06 | +54.3% | Beat |
| 28 Jul 2020 08:00 | -0.10 | -0.04 | +61.5% | Beat |
| 28 Apr 2020 08:00 | 0.02 | -0.02 | -200.0% | Miss |
| 27 Feb 2020 13:00 | 0.06 | 0.10 | +55.1% | Beat |
| 29 Oct 2019 07:00 | 0.06 | 0.07 | +16.7% | Beat |
| 30 Jul 2019 13:00 | 0.06 | 0.07 | +15.3% | Beat |
| 30 Apr 2019 14:00 | 0.05 | 0.07 | +45.8% | Beat |
| 19 Feb 2019 07:00 | 0.04 | 0.06 | +37.1% | Beat |
| 30 Oct 2018 07:00 | 0.02 | 0.05 | +140.9% | Beat |
| 24 Jul 2018 07:00 | 0.04 | 0.05 | +15.4% | Beat |
| 01 May 2018 07:00 | 0.03 | 0.04 | +29.0% | Beat |
| 21 Feb 2018 07:00 | 0.04 | 0.05 | +29.0% | Beat |
| 25 Oct 2017 07:00 | 0.02 | 0.01 | -43.3% | Miss |
| 25 Jul 2017 07:00 | 0.03 | 0.04 | +18.5% | Beat |
| 26 Apr 2017 07:00 | 0.03 | 0.03 | +6.7% | Beat |
| 22 Feb 2017 07:00 | 0.03 | 0.05 | +72.4% | Beat |
| 26 Oct 2016 07:00 | 0.03 | 0.04 | +44.0% | Beat |
| 26 Jul 2016 07:00 | 0.03 | 0.04 | +40.0% | Beat |
| 27 Apr 2016 07:00 | 0.01 | 0.03 | +200.0% | Beat |
| 01 Mar 2016 10:00 | 0.02 | 0.02 | +25.1% | Beat |
| 29 Oct 2015 07:00 | — | — | -100.0% | — |
| 23 Jul 2015 07:00 | -0.01 | — | +100.0% | — |
| 28 Apr 2015 07:00 | -0.01 | -0.01 | 0.0% | In line |
| 24 Feb 2015 07:00 | 0.01 | 0.02 | +100.0% | Beat |
| 30 Oct 2014 07:00 | -0.01 | 0.01 | +200.0% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 727.3M | +10.1% | -108M | -14.9% | -0.84 | -35.5% | -21.8M |
| 2024 | 660.6M | +11.6% | -78.7M | -11.9% | -0.62 | +11.4% | -34M |
| 2023 | 591.6M | +16.1% | -88M | -14.9% | -0.70 | +39.7% | -30.7M |
| 2022 | 509.7M | — | -144.3M | -28.3% | -1.16 | — | -96.9M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 17.01 | 17.67 | 16.11 | 16.54 | -1.78% | 5,232,300 | |
| 02 Nov 2026 – 06 Nov 2026 | 17.66 | 17.66 | 15.90 | 16.84 | -3.11% | 8,085,400 | |
| 26 Oct 2026 – 30 Oct 2026 | 16.62 | 18.15 | 16.61 | 17.38 | +4.76% | 11,856,100 | |
| 19 Oct 2026 – 23 Oct 2026 | 16.90 | 17.30 | 16.07 | 16.59 | -0.36% | 7,823,800 | |
| 12 Oct 2026 – 16 Oct 2026 | 16.35 | 17.45 | 15.86 | 16.65 | +1.83% | 8,656,500 | |
| 05 Oct 2026 – 09 Oct 2026 | 18.48 | 20.15 | 15.41 | 16.35 | -11.48% | 15,241,900 | |
| 28 Sep 2026 – 02 Oct 2026 | 19.02 | 19.75 | 17.74 | 18.47 | -4.45% | 11,240,700 | |
| 21 Sep 2026 – 25 Sep 2026 | 19.92 | 20.05 | 18.27 | 19.33 | -2.91% | 13,315,200 | |
| 14 Sep 2026 – 18 Sep 2026 | 17.36 | 20.03 | 17.36 | 19.91 | +14.95% | 11,952,900 | |
| 08 Sep 2026 – 11 Sep 2026 | 17.15 | 18.00 | 16.95 | 17.32 | -0.35% | 4,873,000 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- NeoGenomics to Participate in Upcoming Investor Conferences (opens in a new tab) 06 Nov 2026 12:05
- Did Narrower Quarterly Loss Just Shift NeoGenomics Stock Investment Narrative? (opens in a new tab) 06 Nov 2026 02:16
- NEO Q3 deep dive: product mix shift and margin expansion drive robust oncology testing growth (opens in a new tab) 03 Nov 2026 07:57
- 5 revealing analyst questions from NeoGenomics’s Q3 earnings call (opens in a new tab) 31 Oct 2026 19:47
- NeoGenomics (NEO) Beat Q3 Expectations, Is The Stock Still Cheap? (opens in a new tab) Simply Wall St. · 29 Oct 2026 17:10
- What NeoGenomics (NEO) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 29 Oct 2026 05:04
- NeoGenomics (NEO) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 29 Oct 2026 04:13
- NeoGenomics (NEO) Q3 Earnings and Revenues Beat Estimates (opens in a new tab) Zacks · 28 Oct 2026 22:30
- NeoGenomics: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 28 Oct 2026 20:59
- NeoGenomics’s (NASDAQ:NEO) Q3 2026 sales beat estimates (opens in a new tab) StockStory · 28 Oct 2026 20:26
- Earnings to watch: NeoGenomics (NEO) reports Q3 results tomorrow (opens in a new tab) StockStory · 27 Oct 2026 15:50
- Why NeoGenomics (NEO) Stock Is Up Today (opens in a new tab) StockStory · 06 Oct 2026 21:32
- Stryker, Neogenomics Announce CEO Transitions; Both Stocks Dive (opens in a new tab) Investor's Business Daily · 06 Oct 2026 21:31
- NeoGenomics Sinks 12% on CEO Succession Plan Despite Revenue Beat (opens in a new tab) TIKR · 06 Oct 2026 18:09
- Did Strong Q3 Outlook and New CEO Plan Just Shift NeoGenomics' (NEO) Investment Narrative? (opens in a new tab) Simply Wall St. · 06 Oct 2026 18:08
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 16.83 USD
- Market cap
- 2.1B
- Exchange
- NasdaqCM
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow NEO and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.